This inventor holds 1 USPTO granted patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Behrooz Vaziri: Innovator in Radiation Dose Determination
Introduction
Behrooz Vaziri is a notable inventor based in Livingston, NJ (US). He has made significant contributions to the field of radiation therapy through his innovative patent. His work focuses on improving the understanding and application of radionuclides in medical treatments.
Latest Patents
Vaziri holds a patent titled "Methods and systems for determining the distribution of radiation dose and response." This invention provides a system, method, and computer program product designed to determine radiation dose from radionuclides used in patient treatment. The technology allows users to visualize and comprehend various factors, such as radionuclide choice, activity distribution in cells, and radiobiological response parameters. These elements are crucial in designing effective treatment plans for therapeutic radiopharmaceuticals tailored to individual patient needs. Vaziri's patent is a testament to his commitment to enhancing patient care through innovative solutions. He has 1 patent to his name.
Career Highlights
Behrooz Vaziri is affiliated with Rutgers, the State University of New Jersey, where he continues to contribute to research and development in his field. His work has implications for improving cancer treatment methodologies and enhancing the effectiveness of radiopharmaceuticals.
Collaborations
Vaziri has collaborated with esteemed colleagues, including Han Wu and Roger W. Howell. These partnerships have fostered a collaborative environment that promotes innovation and the advancement of medical technologies.
Conclusion
Behrooz Vaziri's contributions to the field of radiation therapy through his innovative patent demonstrate his dedication to improving patient outcomes. His work continues to influence the development of personalized treatment plans in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
